MicroRNA Profiling in Oesophageal Adenocarcinoma Cell Lines and Patient Serum Samples Reveals a Role for miR-451a in

Frederike Butz1,2, Ann-Kathrin Eichelmann1,3, George C Mayne1,4

  • 1Flinders Health and Medical Research Institute-Cancer Program, Flinders University, Bedford Park, SA 5042, Australia.

Insights

MicroRNAs (miRNAs) are key to understanding oesophageal adenocarcinoma (OAC) treatment resistance. miR-451a is linked to radiation resistance and patient response, offering potential therapeutic targets.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Oesophageal adenocarcinoma (OAC) patients often exhibit resistance to chemoradiotherapy.
  • Understanding resistance mechanisms is crucial for improving treatment efficacy.
  • MicroRNAs (miRNAs) play a role in regulating gene expression and may influence treatment response.

Purpose of the Study:

  • To investigate the association of miRNAs with resistance to radiation and chemotherapy in OAC.
  • To identify potential miRNA biomarkers for predicting response to chemoradiotherapy.
  • To explore mechanisms of treatment resistance mediated by miRNAs.

Main Methods:

  • Assessed intrinsic radiation and chemotherapy drug resistance in eight OAC cell lines.
  • Performed miRNA expression profiling using TaqMan OpenArray qPCR.
  • Investigated miRNA associations with in vitro treatment responses and patient serum samples.

Main Results:

  • Identified miRNAs uniquely or commonly associated with resistance to radiation, cisplatin, or 5-FU.
  • miR-451a was uniquely associated with radiation resistance in cell lines and nCRT response in patients.
  • Inhibition of miR-451a increased radiosensitivity in an OAC cell line.

Conclusions:

  • miR-451a is a potential biomarker for predicting response to chemoradiotherapy in OAC.
  • Targeting miR-451a may represent a therapeutic strategy to overcome radiation resistance.
  • miRNAs and their target pathways offer insights into OAC treatment resistance mechanisms.